William Callahan
Direktor/Vorstandsmitglied bei MEDISUN PRECISION MEDICINE LTD.
Profil
William Callahan is an Independent Director at Medisun Precision Medicine Ltd.
since 2015.
He was a Senior Director-Manufacturing Operations at Talphera, Inc. and a Vice President-Operations at Assertio Therapeutics, Inc. from 2002 to 2012.
He obtained an undergraduate degree from San Francisco State University.
Aktive Positionen von William Callahan
Unternehmen | Position | Beginn |
---|---|---|
MEDISUN PRECISION MEDICINE LTD. | Direktor/Vorstandsmitglied | 01.07.2015 |
Ehemalige bekannte Positionen von William Callahan
Unternehmen | Position | Ende |
---|---|---|
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Geschäftsführer | 01.02.2012 |
TALPHERA, INC. | Corporate Officer/Principal | - |
Ausbildung von William Callahan
San Francisco State University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
TALPHERA, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Health Technology |
Medisun Precision Medicine Ltd.
Medisun Precision Medicine Ltd. BiotechnologyHealth Technology Medisun Precision Medicine Ltd. is a biotechnology company, which focuses on developing novel neurological therapies to be directly delivered into specific regions of the brain. It portfolio includes ACX-31 program to deliver two chemotherapy drugs, temozolomide in combination with BCNU, locally to brain tumor sites. The company was founded on August 29, 2012 and is headquartered in Majuro, Marshall Islands. | Health Technology |